Commonwealth Equity Services
SLDB icon

Commonwealth Equity Services’s Solid Biosciences SLDB Stock Holding History

Commonwealth Equity Services’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,852
Closed -$61.2K – 4439
2025
Q4 		$61.2K Hold
10,852
– – ﹤0.01% 4165
2025
Q3 		$67K Buy
+10,852
New +$63.5K ﹤0.01% 4135

Other funds holding SLDB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Commonwealth Equity Services's SLDB Position: Q1 2026 in Review

Commonwealth Equity Services sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 10,852 shares — an estimated $61.2K sold.

Commonwealth Equity Services first reported a position in SLDB in Q3 2025 and held it in 2 quarters. The position peaked at $67K in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Commonwealth Equity Services reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 10,852 Solid Biosciences shares in Q1 2026, an estimated $61.2K.
  • Commonwealth Equity Services first reported a position in Solid Biosciences in Q3 2025 and held it in 2 quarters.
  • Commonwealth Equity Services's Solid Biosciences position peaked at $67K in Q3 2025.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.